openPR Logo
Press release

Global Veletri Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032

04-03-2025 01:02 PM CET | Chemicals & Materials

Press release from: intelmarketresearch

The global Decanoyl Chloride market was valued at $29.54 million in 2024 and is projected to reach $40.18 million by 2031, reflect

The global Decanoyl Chloride market was valued at $29.54 million in 2024 and is projected to reach $40.18 million by 2031, reflect

The global Veletri market was valued at US$ 312 million in 2024 and is projected to reach US$ 412 million by 2030, growing at a CAGR of 4.8% during the forecast period (2024-2030).

Get free sample of this report at :v https://www.intelmarketresearch.com/download-free-sample/700/global-veletri-2025-2032

Veletri is the brand name for epoprostenol, a potent medication primarily used to treat pulmonary arterial hypertension (PAH). PAH is a progressive condition characterized by high blood pressure in the arteries of the lungs, leading to increased strain on the heart. As a prostacyclin analog, Veletri works by dilating the blood vessels in the lungs, reducing blood clotting, and improving blood flow. The medication is administered as a continuous intravenous infusion, making it a crucial treatment for patients with advanced PAH when oral therapies prove ineffective.

▶ Market Size
In the United States, the market was valued at US$ 102 million in 2024 and is expected to reach US$ 130 million by 2030, registering a CAGR of 4.1%.

The market growth is driven by factors such as:
The increasing prevalence of PAH.
Advancements in intravenous drug delivery methods.
Rising healthcare expenditures worldwide.

▶ Market Dynamics (Drivers, Restraints, Opportunities, and Challenges)

▶ Drivers
• Rising Prevalence of Pulmonary Arterial Hypertension (PAH)
The increasing cases of PAH, particularly among aging populations, are driving the demand for effective treatments like Veletri.
• Advancements in Drug Delivery Systems
Innovations in intravenous infusion pumps and catheter-based delivery methods have improved patient compliance and treatment efficacy.
• Growing Healthcare Expenditure
Higher healthcare spending worldwide has enhanced accessibility and affordability for PAH treatments.
• Favorable Regulatory Support
Regulatory bodies like the FDA and EMA are streamlining drug approvals, ensuring a faster market entry for new and improved treatments.

▶ Restraints
High Cost of Treatment
Veletri requires continuous infusion, necessitating expensive equipment and monitoring, making it less accessible in low-income regions.
Availability of Alternative PAH Treatments
Competing oral and inhalable PAH medications, including other prostacyclin analogs and endothelin receptor antagonists, present market competition.

▶ Opportunities
• Expansion in Emerging Markets
Rapid healthcare infrastructure development in Asia-Pacific and Latin America presents growth opportunities.
• Development of Biosimilars
Companies investing in biosimilar versions of epoprostenol could drive market competition and affordability.

▶ Challenges
• Complicated Administration Process
• Veletri's continuous infusion requirement demands careful patient monitoring, limiting its adoption compared to oral alternatives.
• Side Effects and Safety Concerns
• Potential adverse effects, including hypotension and bleeding risks, may hinder widespread usage.

▶ Regional Analysis
▶ North America
• Dominates the market due to a high prevalence of PAH, well-established healthcare infrastructure, and significant R&D investments.
• The United States holds the largest market share, accounting for nearly one-third of the global Veletri market.

▶ Europe
• Germany, France, and the UK lead the European Veletri market due to a strong pharmaceutical presence and favorable reimbursement policies.

▶ Asia-Pacific
• China and Japan are experiencing increasing demand, driven by rising PAH awareness and healthcare advancements.
• India and Southeast Asia hold untapped potential, but affordability remains a challenge.

▶ South America & Middle East & Africa (MEA)
Brazil and Argentina exhibit moderate growth with improving healthcare access.
The MEA region faces slow adoption due to economic constraints and limited availability of advanced therapies.

Get free sample of this report at :v https://www.intelmarketresearch.com/download-free-sample/700/global-veletri-2025-2032

▶ Competitor Analysis
Key players in the Veletri market include:

• Pfizer (US)
• Sanofi S.A (France)
• Bayer HealthCare Pharmaceuticals (Germany)
• Actelion Pharmaceuticals (Switzerland)
• Daiichi Sankyo (Japan)
• Gilead Sciences (US)
• GlaxoSmithKline Plc (UK)
• United Therapeutics Corp (US)
• Novartis Group (Switzerland)
• Cipla Limited (India)

▶ Market Segmentation (by Application)
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

▶ Market Segmentation (by Type)
• Oral Medication
• Injection

▶ Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Colombia, Rest of South America)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

▶ FAQ Section

1. What is the current market size of the Global Veletri Market?
The global Veletri market was valued at US$ 312 million in 2024 and is projected to grow to US$ 412 million by 2030, at a CAGR of 4.8%.

2. Which are the key companies operating in the Veletri Market?
Major players include Pfizer, Sanofi S.A, Bayer HealthCare, Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corp, and GlaxoSmithKline Plc.

3. What are the key growth drivers in the Veletri Market?
The key growth drivers include:

The rising prevalence of PAH.
Advancements in intravenous drug delivery.
Increased healthcare expenditure.
Favorable regulatory approvals.

4. Which regions dominate the Veletri Market?
The United States dominates the market, followed by Europe and Asia-Pacific.

5. What are the emerging trends in the Veletri Market?
Trends include:
Development of biosimilars.
Increased investment in PAH research.
Expansion into emerging markets.

Get free sample of this report at :v https://www.intelmarketresearch.com/download-free-sample/700/global-veletri-2025-2032

Visit more Trending reports :
https://sites.google.com/view/intel-market-research/top-reports/soil-monitoring-system-market
https://sites.google.com/view/intel-market-research/top-reports/duty-free-and-travel-retail-market-2025
https://sites.google.com/view/intel-market-research/top-reports/drones-in-travel-and-tourism-market-2025-2032
https://sites.google.com/view/intel-market-research/top-reports/global-golf-and-sport-mats-market-2025-2032
https://sites.google.com/view/intel-market-research/top-reports/global-pet-travel-services-market-2025-2032
https://sites.google.com/view/intel-market-research/top-reports/leisure-travel-services-market-2025-2032
https://sites.google.com/view/intel-market-research/top-reports/golf-apparel-market-2025-2032
https://sites.google.com/view/intel-market-research/top-reports/global-business-travel-accident-insurance-market-2025-2032
https://sites.google.com/view/intel-market-research/top-reports/soil-amendment-and-conditioner-market-2025-2032
https://sites.google.com/view/intel-market-research/top-reports/metformin-drugs-market-global-outlook-and-forecast-2025-2032-2025
https://sites.google.com/view/intel-market-research/top-reports/wellness-tourism-market-2025-2032

203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014.

ABOUT US
Established ourselves in the year 2015, Intel Market Reports is a popular market research company that provides an in-depth quantified market research report.

The Purpose - To deliver effective and fruit-bearing market research reports.

Our portfolio includes the list of 30+ companies belonging to the Fortune 500 list. We have achieved this milestone in less than half a decade.

What sets us apart?
We are been trusted by the most number of companies around the globe and these companies rely on our reports in their decision-making process.

We believe in time-ethics, which is to submit the report to our clients in the stipulated time frame and thus work round the clock to meet our deadlines.

Our database includes more than 1 million market reports and 50,000 company profiles worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Veletri Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032 here

News-ID: 3953688 • Views:

More Releases from intelmarketresearch

Microbiome Drugs Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032
Microbiome Drugs Market Growth Analysis, Market Dynamics, Key Players and Innova …
The global microbiome drugs market was valued at approximately USD 222 million in 2023 and is projected to grow at a remarkable compound annual growth rate (CAGR) of 34.60%, reaching an estimated USD 3219.28 million by 2032. This exponential growth is attributed to increasing research and development, rising awareness of gut health, and growing investment in biotechnology and personalized medicine. Get Free report at this sample : https://www.intelmarketresearch.com/download-free-sample/812/global-microbiome-drugs-forecast-2025-2032 Microbiome drugs are
Generalized Anxiety Disorder Treatment Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032
Generalized Anxiety Disorder Treatment Market Growth Analysis, Market Dynamics, …
The Global Generalized Anxiety Disorder (GAD) Treatment Market encompasses all medical, therapeutic, and supportive products and services used to diagnose, manage, and treat generalized anxiety disorder. GAD is a chronic mental health condition characterized by persistent, excessive, and often irrational worry about everyday events. It significantly affects quality of life and daily functioning. Treatments for GAD include a combination of psychotherapy, pharmacological interventions, and lifestyle management techniques. Cognitive Behavioral Therapy
Ceramic IC Packages Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032
Ceramic IC Packages Market Growth Analysis, Market Dynamics, Key Players and Inn …
The global Ceramic IC Packages market was valued at USD 3.42 billion in 2024 and is projected to reach USD 6.15 billion by 2032, growing at a CAGR of 7.6% from 2025 to 2032. This growth is driven by increasing demand in sectors like aerospace & defense, telecommunications, automotive electronics, and medical devices. In North America, the market was valued at USD 1.02 billion in 2024 and is expected to
Automotive Windscreen Washer Fluid Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032
Automotive Windscreen Washer Fluid Market Growth Analysis, Market Dynamics, Key …
The automotive windscreen washer fluid market is witnessing robust growth worldwide, fueled by rising vehicle ownership, increasing demand for vehicle maintenance products, and growing awareness about driving safety. In 2024, the global automotive windscreen washer fluid market was valued at USD 2.85 billion and is projected to reach USD 4.32 billion by 2032, growing at a CAGR of 5.3% from 2025 to 2032. Get free report of this sample :

All 5 Releases


More Releases for Veletri

Growing PAH Cases Drive Need For Advanced Therapeutic Solutions: A Key Driver Po …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Current VELETRI Market Size and Its Estimated Growth Rate? The market size of VELETRI has been experiencing robust growth in the past few years. It is projected to rise from $1.34 billion in 2024 to $1.45 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. The
In-Depth Analysis of the VELETRI Market: Growth Opportunities, Key Trends, and F …
What combination of drivers is leading to accelerated growth in the veletri market? The growth in healthcare spending is expected to fuel the expansion of the VELETRI market moving forward. Healthcare expenditures are increasing due to factors such as aging populations, advancements in medical technology, a rise in chronic diseases, and higher costs for drugs and treatments. Increased healthcare spending facilitates the affordability, accessibility, and continued research of VELETRI, ensuring it
Veletri Market Analysis By Top Keyplayers - Pfizer, Sanofi S.A, Bayer HealthCare …
The "Veletri Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Veletri Market, 2024-2031 Verified Market Research's most recent report, "Veletri Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the
Veletri Market Analysis By Top Keyplayers - Pfizer, Sanofi S.A, Bayer HealthCare …
The "Veletri Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Veletri Market, 2024-2031 Verified Market Research's most recent report, "Veletri Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the
Actelion Pharmaceutical's VELETRI (epoprostenol) market size expected to increas …
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on VELETRI (Actelion Pharmaceuticals) providing insights into the drug market landscape and market forecast of VELETRI upto 2032. The report, titled "VELETRI (epoprostenol) Market Size, Forecast, and Drug Insight - 2032" is now available for review and analysis. Are you interested in finding out the projected market size of VELETRI in 2032? VELETRI Market
Veletri Market Report- Trends, Business Growth Opportunities, Top Companies | Ar …
The Veletri Market research report identifies key market trends and focuses on the significant trends and factors driving the market growth. In addition, Veletri Market analyses the global and key regions' market potentials and advantages, opportunities and challenges, restraints and risks. Finally, the Veletri Market research report strategically analyzes each submarket concerning Veletri Market growth trends and their contribution. Download FREE PDF of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5480664 Veletri market is segmented by